192. コケイン症候群 Disease details / Clinical trials / Drug dev / DR info


臨床試験数 : 4 / 薬物数 : 7 - (DrugBank : 3) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 51

薬物ごとの開発者(Primary Sponsor)、臨床試験情報(抜粋)です。
Prodarsan   
   DNage B.V.
      2010   Phase 1/Phase 2   NCT01142154   United States;
Quercetin   
   The First Medical Center of PLA General Hospital
      2019   Phase 0   ChiCTR1900026719   China;
Sirolimus   
   Premier Specialists, Australia
      2016   Phase 2   NCT03016715   Australia;
Sirolimus,   
   Stanford University
      2016   Phase 2   NCT02960997   United States;
Vehicle   
   Premier Specialists, Australia
      2016   Phase 2   NCT03016715   Australia;
   Stanford University
      2016   Phase 2   NCT02960997   United States;
Vitamin C   
   The First Medical Center of PLA General Hospital
      2019   Phase 0   ChiCTR1900026719   China;